Contents:

1 TOC 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 What Is This Report About? 3 Definitions of Markets Covered in the Report 3.1 In Vitro Diagnostics 3.2 Clinical Chemistry 3.3 Genetic Testing 3.4 Haematology 3.5 Histology And Cytology 3.6 Immuno Chemistry 3.7 Infectious Immunology 3.8 Microbiology Culture 4 In Vitro Diagnostics in Asia-Pacific 4.1 In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), 2000-2015 4.2 In Vitro Diagnostics, Asia-Pacific, Company share (2007-2008) 5 In Vitro Diagnostics In Japan 5.1 In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015 5.2 In Vitro Diagnostics, Japan, Distribution Share (2007-2008) 5.2.1 Clinical Chemistry Distribution Share (2007-2008) 5.2.2 Genetic Testing Distribution Share (2007-2008) 5.2.3 Haematology Distribution Share (2007-2008) 5.2.4 Histology And Cytology Distribution Share (2007-2008) 5.2.5 Immuno Chemistry Distribution Share (2007-2008) 5.2.6 Infectious Immunology Distribution Share (2007-2008) 5.2.7 Microbiology Culture Distribution Share (2007-2008) 5.3 In Vitro Diagnostics, Japan, Company Share (2007-2008) 5.3.1 In Vitro Diagnostics, Japan, Company Share (2007-2008) 5.3.2 Clinical Chemistry, Japan, Company Share (2007-2008) 5.3.3 Genetic Testing, Japan, Company Share (2007-2008) 5.3.4 Haematology, Japan, Company Share (2007-2008) 5.3.5 Histology And Cytology, Japan, Company Share (2007-2008) 5.3.6 Immuno Chemistry, Japan, Company Share (2007-2008) 5.3.7 Infectious Immunology, Japan, Company Share (2007-2008) 5.3.8 Microbiology Culture, Japan, Company Share (2007-2008) 6 In Vitro Diagnostics In Australia 6.1 In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015 6.2 In Vitro Diagnostics, Australia, Distribution Share (2007-2008) 6.2.1 Clinical Chemistry Distribution Share (2007-2008) 6.2.2 Genetic Testing Distribution Share (2007-2008) 6.2.3 Haematology Distribution Share (2007-2008) 6.2.4 Histology And Cytology Distribution Share (2007-2008) 6.2.5 Immuno Chemistry Distribution Share (2007-2008) 6.2.6 Infectious Immunology Distribution Share (2007-2008) 6.2.7 Microbiology Culture Distribution Share (2007-2008) 6.3 In Vitro Diagnostics, Australia, Company Share (2007-2008) 6.3.1 In Vitro Diagnostics, Australia, Company Share (2007-2008) 6.3.2 Clinical Chemistry, Australia, Company Share (2007-2008) 6.3.3 Genetic Testing, Australia, Company Share (2007-2008) 6.3.4 Haematology, Australia, Company Share (2007-2008) 6.3.5 Histology And Cytology, Australia, Company Share (2007-2008) 6.3.6 Immuno Chemistry, Australia, Company Share (2007-2008) 6.3.7 Infectious Immunology, Australia, Company Share (2007-2008) 6.3.8 Microbiology Culture, Australia, Company Share (2007-2008) 7 In Vitro Diagnostics In China 7.1 In Vitro Diagnostics, China, Overall Revenue ($ mn), 2000-2015 7.2 In Vitro Diagnostics, China, Distribution Share (2007-2008) 7.2.1 Clinical Chemistry Distribution Share (2007-2008) 7.2.2 Genetic Testing Distribution Share (2007-2008) 7.2.3 Haematology Distribution Share (2007-2008) 7.2.4 Histology And Cytology Distribution Share (2007-2008) 7.2.5 Immuno Chemistry Distribution Share (2007-2008) 7.2.6 Infectious Immunology Distribution Share (2007-2008) 7.2.7 Microbiology Culture Distribution Share (2007-2008) 7.3 In Vitro Diagnostics, China, Company Share (2007-2008) 7.3.1 In Vitro Diagnostics, China, Company Share (2007-2008) 7.3.2 Clinical Chemistry, China, Company Share (2007-2008) 7.3.3 Genetic Testing, China, Company Share (2007-2008) 7.3.4 Haematology, China, Company Share (2007-2008) 7.3.5 Histology And Cytology, China, Company Share (2007-2008) 7.3.6 Immuno Chemistry, China, Company Share (2007-2008) 7.3.7 Infectious Immunology, China, Company Share (2007-2008) 7.3.8 Microbiology Culture, China, Company Share (2007-2008) 8 In Vitro Diagnostics In India 8.1 In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015 8.2 In Vitro Diagnostics, India, Distribution Share (2007-2008) 8.2.1 Clinical Chemistry Distribution Share (2007-2008) 8.2.2 Genetic Testing Distribution Share (2007-2008) 8.2.3 Haematology Distribution Share (2007-2008) 8.2.4 Histology And Cytology Distribution Share (2007-2008) 8.2.5 Immuno Chemistry Distribution Share (2007-2008) 8.2.6 Infectious Immunology Distribution Share (2007-2008) 8.2.7 Microbiology Culture Distribution Share (2007-2008) 8.3 In Vitro Diagnostics, India, Company Share (2007-2008) 8.3.1 In Vitro Diagnostics, India, Company Share (2007-2008) 8.3.2 Clinical Chemistry, India, Company Share (2007-2008) 8.3.3 Genetic Testing, India, Company Share (2007-2008) 8.3.4 Haematology, India, Company Share (2007-2008) 8.3.5 Histology And Cytology, India, Company Share (2007-2008) 8.3.6 Immuno Chemistry, India, Company Share (2007-2008) 8.3.7 Infectious Immunology, India, Company Share (2007-2008) 8.3.8 Microbiology Culture, India, Company Share (2007-2008) 9 Overview of Key Companies in Asia-Pacific In Vitro Diagnostics Market 9.1 Sysmex Corporation 9.1.1 Company Overview 9.1.2 Sysmex Corporation Pipeline Products 9.2 Siemens Healthcare 9.2.1 Company Overview 9.3 Qiagen N.V 9.3.1 Company Overview 9.3.2 Qiagen N.V. Pipeline Products 9.4 Phadia AB 9.4.1 Company Overview 9.4.2 Phadia AB Pipeline Products 9.5 Ortho-Clinical Diagnostics Inc 9.5.1 Company Overview 9.5.2 Ortho-Clinical Diagnostics Inc. Pipeline Products 9.6 Mindray Medical International Limited 9.6.1 Company Overview 9.6.2 Mindray Medical International Limited Pipeline Products 9.7 Hologic, Inc 9.7.1 Company Overview 9.7.2 Hologic, Inc. Pipeline Products 9.8 Gen-Probe Incorporated 9.8.1 Company Overview 9.8.2 Gen-Probe Incorporated Pipeline Products 9.9 F. Hoffmann-La Roche Ltd 9.9.1 Company Overview 9.10 Digene Corporation 9.10.1 Company Overview 9.11 DiaSorin S.p.A 9.11.1 Company Overview 9.11.2 DiaSorin S.p.A Pipeline Products 9.12 Dade Behring Holdings, Inc 9.12.1 Company Overview 9.13 Bio-Rad Laboratories, Inc 9.13.1 Company Overview 9.14 bioMerieux S.A 9.14.1 Company Overview 9.14.2 Biomerieux Sa Pipeline Products 9.15 Becton, Dickinson and Company 9.15.1 Company Overview 9.15.2 Becton, Dickinson and Company Pipeline Products 9.16 Beckman Coulter, Inc 9.16.1 Company Overview 9.16.2 Beckman Coulter, Inc. Pipeline Products 9.17 Abbott Laboratories 9.17.1 Company Overview 9.17.2 Abbott Laboratories Pipeline Products 9.18 Eiken Chemical Co.,Ltd 9.18.1 Company Overview 9.18.2 Eiken Chemical Co.,Ltd. Pipeline Products 9.19 Advanced Life Science Institute, Inc 9.19.1 Company Overview 10 Financial Deals Landscape 10.1 Acquisition 10.1.1 Metropolis Health Services Plans To Acquire Diagnostic Labs 10.1.2 PerkinElmer Completes Acquisition Of Sym-Bio LifeScience 10.1.3 PerkinElmer Acquires Surendra Genetic Labs 10.1.4 Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS 10.2 Private Equity 10.2.1 Thyrocare Technologies To Raise $51.81 Million From Private Equity Firms 10.3 Venture Financing 10.3.1 ReaMetrix Secures $2.1 Million In Venture Financing 10.4 Equity Offerings 10.4.1 NuSep Completes Private Placement Of $0.76 Million 10.4.2 Starpharma Holdings Completes Private Placement Of Shares For $14.53 Million 10.4.3 Fluorotechnics Announces Rights Issue For $1 Million 10.4.4 Medical Therapies Completes Private Placement Of $0.44 Million 10.5 Debt Offerings 10.5.1 Sonic Healthcare Prices Private Placement Of 5.23% Notes For $95 Million 10.5.2 Sonic Healthcare Prices Private Placement Of 5.73% Notes For $155 Million 10.5.3 HealthLinx Completes First Tranche Private Placement Of Convertible Note For $0.23 Million 10.5.4 Agenix Completes Private Placement Of 10% Convertible Notes For $0.8 Million 10.6 Partnerships 10.6.1 Celera Enters Into Licensing Agreement With Medical Therapies 10.6.2 Rosetta Genomics Enters Into An Agreement With Genetic Technologies 10.6.3 Anteo Diagnostics Enters Into An Agreement With DioSion Diagnostics 10.6.4 IRIS International Enters Into Exclusive Distribution Agreement With Fujirebio 10.6.5 Rosetta Genomics Enters Into Distribution Agreement With Super Religare Laboratories 10.6.6 DxS Signs Cross-Licensing Agreement With Epigenomics 10.6.7 Prodesse Enters Into A licensing Agreement With Abbott Laboratories 11 Recent Developments 11.1 Strategy And Business Planning 11.1.1 Dec 15, 2009: Covance Opens New Clinical Development Offices In South Korea And India, Expands Offices In Japan And Hong Kong 11.1.2 Oct 15, 2009: Tyrian Seeks New Partner Opportunities For Tuberculosis Diagnostic Tests 11.1.3 Sep 08, 2009: Qiagen Inaugurates New Asia Headquarters In Shanghai 11.2 Government and Public Interest 11.2.1 Aug 19, 2009: Quick And Accurate Way Of Diagnosing Endometriosis 11.3 Product News 11.3.1 Jul 20, 2009: Itamar Medical Receives SHONIN Approval For EndoPAT Device 11.3.2 Jul 09, 2009: ZyGEM Announces Availability Of A New Application Note Documenting PrepGEM Bacteria DNA Extraction Kit 11.3.3 Apr 29, 2009: Seegene Launches Seeplex Diarrhea ACE Detection Test 11.3.4 Mar 03, 2009: Seegene Announces The Launch Of Seeplex MTB ACE Detection Test 11.3.5 Feb 23, 2009: Spectral Diagnostics Announces New Data Findings On The Clinical Utility Of EAA At The 13th Annual Critical Care For Endotoxemia Conference 12 Appendix 12.1 Global Markets Direct Research Methodology 12.2 Secondary Research 12.3 Primary Research 12.4 Models 12.5 Forecasts 12.6 Expert Panel Validation 12.7 Currency Conversion 12.8 Contact Us 12.9 Disclaimer List of Tables: Table 1: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), 2000-2015 Table 2: In Vitro Diagnostics, Asia-Pacific, Cross-Category Analysis, 2000-2015 Table 3: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), Historic, 2000-2008 Table 4: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), Forecast, 2008-2015 Table 5: In Vitro Diagnostics, Asia-Pacific, Company share by Revenue ($ mn), 2007-2008 Table 6: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015 Table 7: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Historic, 2000-2008 Table 8: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Forecast, 2008-2015 Table 9: Clinical Chemistry, Japan, Distribution Share by Revenue ($mn), 2007-2008 Table 10: Genetic Testing, Japan, Distribution Share by Revenue ($mn), 2007-2008 Table 11: Haematology, Japan, Distribution Share by Revenue ($mn), 2007-2008 Table 12: Histology And Cytology, Japan, Distribution Share by Revenue ($mn), 2007-2008 Table 13: Immuno Chemistry, Japan, Distribution Share by Revenue ($mn), 2007-2008 Table 14: Infectious Immunology, Japan, Distribution Share by Revenue ($mn), 2007-2008 Table 15: Microbiology Culture, Japan, Distribution Share by Revenue ($mn), 2007-2008 Table 16: In Vitro Diagnostics, Japan, Company Share by Revenue ($ mn), 2007-2008 Table 17: Clinical Chemistry, Japan, Company Share by Revenue ($ mn), 2007-2008 Table 18: Genetic Testing, Japan, Company Share by Revenue ($ mn), 2007-2008 Table 19: Haematology, Japan, Company Share by Revenue ($ mn), 2007-2008 Table 20: Histology And Cytology, Japan, Company Share by Revenue ($ mn), 2007-2008 Table 21: Immuno Chemistry, Japan, Company Share by Revenue ($ mn), 2007-2008 Table 22: Infectious Immunology, Japan, Company Share by Revenue ($ mn), 2007-2008 Table 23: Microbiology Culture, Japan, Company Share by Revenue ($ mn), 2007-2008 Table 24: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015 Table 25: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Historic, 2000-2008 Table 26: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Forecast, 2008-2015 Table 27: Clinical Chemistry, Australia, Distribution Share by Revenue ($mn), 2007-2008 Table 28: Genetic Testing, Australia, Distribution Share by Revenue ($mn), 2007-2008 Table 29: Haematology, Australia, Distribution Share by Revenue ($mn), 2007-2008 Table 30: Histology And Cytology, Australia, Distribution Share by Revenue ($mn), 2007-2008 Table 31: Immuno Chemistry, Australia, Distribution Share by Revenue ($mn), 2007-2008 Table 32: Infectious Immunology, Australia, Distribution Share by Revenue ($mn), 2007-2008 Table 33: Microbiology Culture, Australia, Distribution Share by Revenue ($mn), 2007-2008 Table 34: In Vitro Diagnostics, Australia, Company Share by Revenue ($ mn), 2007-2008 Table 35: Clinical Chemistry, Australia, Company Share by Revenue ($ mn), 2007-2008 Table 36: Genetic Testing, Australia, Company Share by Revenue ($ mn), 2007-2008 Table 37: Haematology, Australia, Company Share by Revenue ($ mn), 2007-2008 Table 38: Histology And Cytology, Australia, Company Share by Revenue ($ mn), 2007-2008 Table 39: Immuno Chemistry, Australia, Company Share by Revenue ($ mn), 2007-2008 Table 40: Infectious Immunology, Australia, Company Share by Revenue ($ mn), 2007-2008 Table 41: Microbiology Culture, Australia, Company Share by Revenue ($ mn), 2007-2008 Table 42: In Vitro Diagnostics, China, Overall Revenue ($ mn), 2000-2015 Table 43: In Vitro Diagnostics, China, Overall Revenue ($ mn), Historic, 2000-2008 Table 44: In Vitro Diagnostics, China, Overall Revenue ($ mn), Forecast, 2008-2015 Table 45: Clinical Chemistry, China, Distribution Share by Revenue ($mn), 2007-2008 Table 46: Genetic Testing, China, Distribution Share by Revenue ($mn), 2007-2008 Table 47: Haematology, China, Distribution Share by Revenue ($mn), 2007-2008 Table 48: Histology And Cytology, China, Distribution Share by Revenue ($mn), 2007-2008 Table 49: Immuno Chemistry, China, Distribution Share by Revenue ($mn), 2007-2008 Table 50: Infectious Immunology, China, Distribution Share by Revenue ($mn), 2007-2008 Table 51: Microbiology Culture, China, Distribution Share by Revenue ($mn), 2007-2008 Table 52: In Vitro Diagnostics, China, Company Share by Revenue ($ mn), 2007-2008 Table 53: Clinical Chemistry, China, Company Share by Revenue ($ mn), 2007-2008 Table 54: Genetic Testing, China, Company Share by Revenue ($ mn), 2007-2008 Table 55: Haematology, China, Company Share by Revenue ($ mn), 2007-2008 Table 56: Histology And Cytology, China, Company Share by Revenue ($ mn), 2007-2008 Table 57: Immuno Chemistry, China, Company Share by Revenue ($ mn), 2007-2008 Table 58: Infectious Immunology, China, Company Share by Revenue ($ mn), 2007-2008 Table 59: Microbiology Culture, China, Company Share by Revenue ($ mn), 2007-2008 Table 60: In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015 Table 61: In Vitro Diagnostics, India, Overall Revenue ($ mn), Historic, 2000-2008 Table 62: In Vitro Diagnostics, India, Overall Revenue ($ mn), Forecast, 2008-2015 Table 63: Clinical Chemistry, India, Distribution Share by Revenue ($mn), 2007-2008 Table 64: Genetic Testing, India, Distribution Share by Revenue ($mn), 2007-2008 Table 65: Haematology, India, Distribution Share by Revenue ($mn), 2007-2008 Table 66: Histology And Cytology, India, Distribution Share by Revenue ($mn), 2007-2008 Table 67: Immuno Chemistry, India, Distribution Share by Revenue ($mn), 2007-2008 Table 68: Infectious Immunology, India, Distribution Share by Revenue ($mn), 2007-2008 Table 69: Microbiology Culture, India, Distribution Share by Revenue ($mn), 2007-2008 Table 70: In Vitro Diagnostics, India, Company Share by Revenue ($ mn), 2007-2008 Table 71: Clinical Chemistry, India, Company Share by Revenue ($ mn), 2007-2008 Table 72: Genetic Testing, India, Company Share by Revenue ($ mn), 2007-2008 Table 73: Haematology, India, Company Share by Revenue ($ mn), 2007-2008 Table 74: Histology And Cytology, India, Company Share by Revenue ($ mn), 2007-2008 Table 75: Immuno Chemistry, India, Company Share by Revenue ($ mn), 2007-2008 Table 76: Infectious Immunology, India, Company Share by Revenue ($ mn), 2007-2008 Table 77: Microbiology Culture, India, Company Share by Revenue ($ mn), 2007-2008 Table 78: Sysmex Corporation Pipeline Products by Equipment Type Table 79: Sysmex Corporation Pipeline Products By Development Stage Table 80: Sysmex Corporation Pipeline Products By Therapy Area Table 81: Qiagen N.V. Pipeline Products by Equipment Type Table 82: Qiagen N.V. Pipeline Products By Development Stage Table 83: Qiagen N.V. Pipeline Products By Therapy Area Table 84: Phadia AB Pipeline Products by Equipment Type Table 85: Phadia AB Pipeline Products By Development Stage Table 86: Phadia AB Pipeline Products By Therapy Area Table 87: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type Table 88: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage Table 89: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area Table 90: Ortho-Clinical Diagnostics Inc. Pipeline Products By Clinical Trials Table 91: Mindray Medical International Limited Pipeline Products by Equipment Type Table 92: Mindray Medical International Limited Pipeline Products By Therapy Area Table 93: Hologic, Inc. Pipeline Products by Equipment Type Table 94: Hologic, Inc. Pipeline Products By Therapy Area Table 95: Gen-Probe Incorporated Pipeline Products by Equipment Type Table 96: Gen-Probe Incorporated Pipeline Products By Development Stage Table 97: Gen-Probe Incorporated Pipeline Products By Therapy Area Table 98: Gen-Probe Incorporated Pipeline Products By Clinical Trials Table 99: DiaSorin S.p.A Pipeline Products by Equipment Type Table 100: DiaSorin S.p.A Pipeline Products By Development Stage Table 101: DiaSorin S.p.A Pipeline Products By Therapy Area Table 102: Biomerieux Sa Pipeline Products by Equipment Type Table 103: Biomerieux Sa Pipeline Products By Development Stage Table 104: Biomerieux Sa Pipeline Products By Therapy Area Table 105: Biomerieux Sa Pipeline Products By Clinical Trials Table 106: Becton, Dickinson and Company Pipeline Products by Equipment Type Table 107: Becton, Dickinson and Company Pipeline Products By Development Stage Table 108: Becton, Dickinson and Company Pipeline Products By Therapy Area Table 109: Becton, Dickinson and Company Pipeline Products By Clinical Trials Table 110: Beckman Coulter, Inc. Pipeline Products by Equipment Type Table 111: Beckman Coulter, Inc. Pipeline Products By Development Stage Table 112: Beckman Coulter, Inc. Pipeline Products By Therapy Area Table 113: Abbott Laboratories Pipeline Products by Equipment Type Table 114: Abbott Laboratories Pipeline Products By Development Stage Table 115: Abbott Laboratories Pipeline Products By Therapy Area Table 116: Eiken Chemical Co.,Ltd. Pipeline Products by Equipment Type Table 117: Eiken Chemical Co.,Ltd. Pipeline Products By Development Stage Table 118: Eiken Chemical Co.,Ltd. Pipeline Products By Therapy Area Table 119: Metropolis Health Services Plans To Acquire Diagnostic Labs Table 120: PerkinElmer Completes Acquisition Of Sym-Bio LifeScience Table 121: PerkinElmer Acquires Surendra Genetic Labs Table 122: Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS Table 123: Thyrocare Technologies To Raise $51.81 Million From Private Equity Firms Table 124: ReaMetrix Secures $2.1 Million In Venture Financing Table 125: NuSep Completes Private Placement Of $0.76 Million Table 126: Starpharma Holdings Completes Private Placement Of Shares For $14.53 Million Table 127: Fluorotechnics Announces Rights Issue For $1 Million Table 128: Medical Therapies Completes Private Placement Of $0.44 Million Table 129: Sonic Healthcare Prices Private Placement Of 5.23% Notes For $95 Million Table 130: Sonic Healthcare Prices Private Placement Of 5.73% Notes For $155 Million Table 131: HealthLinx Completes First Tranche Private Placement Of Convertible Note For $0.23 Million Table 132: Agenix Completes Private Placement Of 10% Convertible Notes For $0.8 Million Table 133: Celera Enters Into Licensing Agreement With Medical Therapies Table 134: Rosetta Genomics Enters Into An Agreement With Genetic Technologies Table 135: Anteo Diagnostics Enters Into An Agreement With DioSion Diagnostics Table 136: IRIS International Enters Into Exclusive Distribution Agreement With Fujirebio Table 137: Rosetta Genomics Enters Into Distribution Agreement With Super Religare Laboratories Table 138: DxS Signs Cross-Licensing Agreement With Epigenomics Table 139: Prodesse Enters Into A licensing Agreement With Abbott Laboratories Table 140: USD to Local Currency, Average Exchange Rate 2008 List of Figures: Figure 1: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), 2000-2015 Figure 2: In Vitro Diagnostics, Asia-Pacific, Cross-Category Analysis, 2000-2015 Figure 3: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), Historic, 2000-2008 Figure 4: In Vitro Diagnostics, Asia-Pacific, Overall Revenue ($ mn), Forecast, 2008-2015 Figure 5: In Vitro Diagnostics, Asia-Pacific, Company share (%), 2008 Figure 6: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015 Figure 7: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Historic, 2000-2008 Figure 8: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Forecast, 2008-2015 Figure 9: In Vitro Diagnostics, Japan, Company Share (%), 2008 Figure 10: Clinical Chemistry, Japan, Company Share (%), 2008 Figure 11: Genetic Testing, Japan, Company Share (%), 2008 Figure 12: Haematology, Japan, Company Share (%), 2008 Figure 13: Histology And Cytology, Japan, Company Share (%), 2008 Figure 14: Immuno Chemistry, Japan, Company Share (%), 2008 Figure 15: Infectious Immunology, Japan, Company Share (%), 2008 Figure 16: Microbiology Culture, Japan, Company Share (%), 2008 Figure 17: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015 Figure 18: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Historic, 2000-2008 Figure 19: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Forecast, 2008-2015 Figure 20: In Vitro Diagnostics, Australia, Company Share (%), 2008 Figure 21: Clinical Chemistry, Australia, Company Share (%), 2008 Figure 22: Genetic Testing, Australia, Company Share (%), 2008 Figure 23: Haematology, Australia, Company Share (%), 2008 Figure 24: Histology And Cytology, Australia, Company Share (%), 2008 Figure 25: Immuno Chemistry, Australia, Company Share (%), 2008 Figure 26: Infectious Immunology, Australia, Company Share (%), 2008 Figure 27: Microbiology Culture, Australia, Company Share (%), 2008 Figure 28: In Vitro Diagnostics, China, Overall Revenue ($ mn), 2000-2015 Figure 29: In Vitro Diagnostics, China, Overall Revenue ($ mn), Historic, 2000-2008 Figure 30: In Vitro Diagnostics, China, Overall Revenue ($ mn), Forecast, 2008-2015 Figure 31: In Vitro Diagnostics, China, Company Share (%), 2008 Figure 32: Clinical Chemistry, China, Company Share (%), 2008 Figure 33: Genetic Testing, China, Company Share (%), 2008 Figure 34: Haematology, China, Company Share (%), 2008 Figure 35: Histology And Cytology, China, Company Share (%), 2008 Figure 36: Immuno Chemistry, China, Company Share (%), 2008 Figure 37: Infectious Immunology, China, Company Share (%), 2008 Figure 38: Microbiology Culture, China, Company Share (%), 2008 Figure 39: In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015 Figure 40: In Vitro Diagnostics, India, Overall Revenue ($ mn), Historic, 2000-2008 Figure 41: In Vitro Diagnostics, India, Overall Revenue ($ mn), Forecast, 2008-2015 Figure 42: In Vitro Diagnostics, India, Company Share (%), 2008 Figure 43: Clinical Chemistry, India, Company Share (%), 2008 Figure 44: Genetic Testing, India, Company Share (%), 2008 Figure 45: Haematology, India, Company Share (%), 2008 Figure 46: Histology And Cytology, India, Company Share (%), 2008 Figure 47: Immuno Chemistry, India, Company Share (%), 2008 Figure 48: Infectious Immunology, India, Company Share (%), 2008 Figure 49: Microbiology Culture, India, Company Share (%), 2008 Figure 50: Global Markets Direct Methodology

Companies Mentioned

- Sysmex Corporation - Siemens Healthcare - Qiagen N.V. - Phadia AB - Ortho-Clinical Diagnostics Inc. - Mindray Medical International Limited - Hologic, Inc. - Gen-Probe Incorporated - F. Hoffmann-La Roche Ltd. - Digene Corporation - DiaSorin S.p.A - Dade Behring Holdings, Inc. - Bio-Rad Laboratories, Inc. - bioMerieux S.A. - Becton, Dickinson and Company - Beckman Coulter, Inc. - Abbott Laboratories - Eiken Chemical Co.,Ltd. - Advanced Life Science Institute, Inc.